Clinical Trials on Phosphoric Monoester Hydrolases in Belgium

Total 7 results

  • Novartis
    Completed
    Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients (SBR759)
    Chronic Kidney Disease | Hyperphosphatemia
    Belgium, Italy
  • Alexion
    Recruiting
    Lysosomal Acid Lipase (LAL) Deficiency Registry (ALX-LALD-501)
    Wolman Disease | Cholesterol Ester Storage Disease | Lysosomal Acid Lipase Deficiency | Acid Cholesteryl Ester Hydrolase Deficiency, Type 2 | Acid Lipase Deficiency | LIPA Deficiency | LAL-Deficiency
    France, Belgium, United States, Spain, Germany, Greece, Israel, Italy, Slovenia, United Kingdom, Brazil, Canada, Denmark, Australia, Croatia, Czechia, Ireland, Mexico, Netherlands, Poland, Portugal, Saudi Arabia
  • Centre Hospitalier Universitaire de Liege
    Sanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... and other collaborators
    Recruiting
    Baby Detect : Genomic Newborn Screening
    Congenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditions
    Belgium
  • Ineos Healthcare Limited
    Terminated
    Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
    Chronic Kidney Failure
    United States, Italy, Brazil, Belgium, United Kingdom, Estonia, Bulgaria, Serbia, Israel, Czech Republic, Hungary, Lithuania, Mexico, Slovakia, South Africa
  • Novartis Pharmaceuticals
    Completed
    Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis (SBR759)
    Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy
    Germany, United Kingdom, Italy, Belgium, Sweden, Canada, United States, Australia, Finland, France, Norway, Puerto Rico, Switzerland
  • Amgen
    Completed
    Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
    Hyperparathyroidism | End Stage Renal Disease | Chronic Kidney Disease | Kidney Transplantation | Chronic Renal Failure | Hypophosphatemia | Kidney Disease | Chronic Allograft Nephropathy | Disordered Mineral Metabolism | Post Renal Transplantation
    United States, Canada, France, Italy, Belgium, Switzerland, Spain, Australia, Germany, Austria, Poland
  • Kyowa Kirin Pharmaceutical Development Ltd
    Active, not recruiting
    Registry for Patients With X-Linked Hypophosphatemia (XLH Registry)
    X-Linked Hypophosphatemia
    Spain, Italy, United Kingdom, France, Belgium, Denmark, Germany, Hungary, Portugal, Norway, Switzerland, Israel, Netherlands, Czechia, Bulgaria, Sweden, Slovenia, Ireland, Latvia, Slovakia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe